GENF — Genflow Biosciences Balance Sheet
0.000.00%
- £9.87m
- £9.59m
Annual balance sheet for Genflow Biosciences, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.177 | 0.224 | 2.36 | 0.684 | 0.279 |
| Net Total Receivables | 0 | 0.02 | 0.127 | 0.343 | 0.037 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.18 | 0.277 | 2.62 | 1.07 | 0.384 |
| Net Property, Plant And Equipment | — | — | 0.002 | 0.003 | 0.002 |
| Total Assets | 0.18 | 0.277 | 2.62 | 1.07 | 0.386 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.031 | 0.221 | 0.251 | 0.572 | 0.789 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.031 | 0.221 | 0.251 | 0.572 | 0.789 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 0.149 | 0.055 | 2.37 | 0.5 | -0.403 |
| Total Liabilities & Shareholders' Equity | 0.18 | 0.277 | 2.62 | 1.07 | 0.386 |
| Total Common Shares Outstanding |